DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr | ₹1,150 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹794 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹1,509 Cr |
Mar2021 | ₹761 Cr |
Mar2020 | ₹1,150 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹794 Cr | 11.05 | |
Mar2023 | ₹715 Cr | -52.63 | |
Mar2022 | ₹1,509 Cr | 98.37 | |
Mar2021 | ₹761 Cr | -33.85 | |
Mar2020 | ₹1,150 Cr | - |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹156,337.0 Cr | 5.3% | 3.9% | 51.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,468.0 Cr | 3.4% | 2.2% | 13.6% | Stock Analytics | |
CIPLA | ₹122,075.0 Cr | 3.3% | 1.2% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,125.0 Cr | 4% | 6.3% | 29.2% | Stock Analytics | |
MANKIND PHARMA | ₹106,592.0 Cr | 9.9% | 18.9% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,227.9 Cr | 6.1% | 2.3% | -3.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 5.3% |
3.9% |
51.8% |
SENSEX | 7.5% |
7.6% |
7% |
You may also like the below Video Courses